Quantcast
Last updated on April 19, 2014 at 18:42 EDT

Latest Inflammatory bowel disease Stories

2014-04-12 23:00:25

Transparency Market Research Report Added "Inflammatory Bowel Disease Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019" to its database. Browse full report: http://www.transparencymarketresearch.com/inflammatory-bowel-disease.html. Albany, New York USA (PRWEB) April 12, 2014 Inflammatory bowel disease (IBD) is an immune-mediated disease in which the body’s own immune system attacks the parts of the digestive system of the human body....

2014-04-07 12:27:57

LONDON, April 7, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:EpiCast Report: Ulcerative Colitis - Epidemiology Forecast to 2022EpiCast Report: Ulcerative Colitis - Epidemiology Forecast to 2022 SummaryUlcerative colitis is a chronic inflammatory bowel disease (IBD) that causes ulcers in the innermost lining of the colon and rectum. The colon's ability to absorb water is decreased, which leads to progressive loosening of the stool, bloody...

2014-03-28 11:32:58

A novel method for distinguishing different types of bowel disease using the stool samples of patients has been created by a group of researchers in the UK. It works by analysing the chemical compounds emitted from the samples and could provide cheaper, quicker and more accurate diagnoses, at the point of care, for a group of diseases that have, up until now, been very hard to distinguish. The preliminary results of the test, which have been published today, 28 March, in IOP...

Crohn's Disease Associated With Microbiome Imbalance In The Gut
2014-03-13 05:18:52

Lee Rannals for redOrbit.com - Your Universe Online Researchers writing in the journal Cell Host & Microbe say they have found how the intestinal microbial population of newly diagnosed Crohn’s disease patients is different from other individuals. The team says that Crohn’s patients showed increased levels of harmful bacteria and reduced levels of the beneficial bacteria usually found in a healthy gastrointestinal tract. The research included data from the RISK Stratification...

2014-03-12 08:30:38

The Jeffrey Epstein VI Foundation funds groundbreaking research to prevent Crohns and Colitis Disease. NEW YORK, March 12, 2014 /PRNewswire/ -- Crohns and Colitis Disease is a chronic disease of the lower intestinal track, causing inflammation and a host of crippling symptoms from ulcers to intestinal rupture. The disease affects approximately 700,000 Americans and many more suffer from undiagnosed irritable bowel syndrome. To date, not much is known about the ultimate cause of...

2014-03-11 16:26:53

ATLANTIC CITY, N.J., March 11, 2014 /PRNewswire/ -- A jury in New Jersey returned a $1.59 million verdict to a former Accutane user against N.J.-based pharmaceutical companies Hoffmann La-Roche Inc. and Roche Laboratories. The plaintiff, Kamie Kendall Rees, was prescribed several courses of Accutane for treatment of her acne in the 1990s, starting at the age 12. Shortly thereafter, Ms. Kendall Rees developed ulcerative colitis--a permanent, debilitating disease. Unable to manage...

2014-03-10 16:31:55

Foundation Champions Innovation & Collaboration to Accelerate IBD Breakthroughs OAKLAND, Calif., March 10, 2014 /PRNewswire-USNewswire/ -- The Kenneth Rainin Foundation's 2014 Innovations Symposium: Taming the Microbiome will take place July 15 - 16, 2014, at the Union Square Marriott in San Francisco. The annual event brings together influential and collaborative researchers and institutions, with the common goal of curing Inflammatory Bowel Disease (IBD), a disease that affects...

2014-03-04 23:26:41

With locations in Phoenix and Mesa, Arizona, The Giving Tree Wellness Center provides a holistic approach to pain relief and well-being. They are thrilled to support the Take Steps for Crohn's & Colitis fundraising event on March 29, 2014. Phoenix, AZ (PRWEB) March 04, 2014 At the heart of alternative healing is a holistic approach and strong community. The Giving Tree Wellness Center has locations in Mesa and Phoenix, and focuses largely on pain management for those tackling...

2014-03-03 08:32:34

CCFA Researchers Map Out Strategies to New Drugs and Individualized Therapy for Crohn's Disease and Ulcerative Colitis NEW YORK, March 3, 2014 /PRNewswire/ -- High-powered research teams supported by the Crohn's & Colitis Foundation of America (CCFA) are gearing up for an ambitious new goal: developing individualized treatment approaches for patients with Crohn's disease and ulcerative colitis (UC), also known as inflammatory bowel diseases (IBD), through their Genetics and...

2014-02-26 08:28:31

OKLAHOMA CITY, Feb. 26, 2014 /PRNewswire/ -- Altheus Therapeutics, Inc., announced completion of dosing in ZA201, a double-blind, active-controlled Phase 2 trial evaluating the efficacy and safety of Zoenasa® Rectal Gel versus mesalamine enema in 120 patients with left-sided ulcerative colitis. The primary endpoint of ZA201 is reduction in the Ulcerative Colitis Disease Activity Index (UCDAI) at 6 weeks. Secondary endpoints include endoscopic remission, reduction in UCDAI at 3...